SOURCE: Spacelabs Healthcare

May 05, 2008 07:00 ET

Spacelabs Healthcare Introduces New Application Suite ICS G2 at the 35th Annual National Teaching Institute and Critical Care Exposition in Chicago (May 3-8, 2008)

Clinical Synchronization Speeds Care Decisions

ISSAQUAH, WA--(Marketwire - May 5, 2008) - Spacelabs Healthcare, a pioneer in the field of patient monitoring, has introduced the newest advance in its clinical application suite, the ICS G2. Designed in partnership with clinicians, the ICS G2 offers improved efficiency and information flow, working the way that nurses want to work.

"In developing the ICS G2, we applied clinical logic to the presentation of data, creating a tool that works the way our users do," said Joe Davin, Group President, North American Operations. "For example, the data is clinically synchronized so that different views of the same event provide more complete information enabling faster clinical decisions."

The ICS G2 is a completely integrated application suite that makes patient data accessible anywhere on the hospital network. It creates a single consolidated patient record, featuring a series of views that permit the clinician to zero in on precisely the information needed to understand a critical event or to see the big picture. Trends can be custom-configured, alarm events can be reviewed at the touch of a button, and treatment interventions can be evaluated with its "smart disclosure" and built-in Holter analysis features. All of these benefits are available anywhere in the hospital, the doctor's networked office or home.

As Spacelabs Healthcare celebrates 50 years of innovation in 2008, the ICS G2 continues a tradition of clinical and technological excellence. It is specifically designed to help clinicians help their patients by automating documentation, minimizing errors and presenting accurate, easily-viewed information.

About Spacelabs Healthcare, Inc.

Spacelabs Healthcare, Inc. ( is an international developer, manufacturer and distributor of medical equipment and services including solutions for patient monitoring and connectivity, anesthesia delivery and ventilation, diagnostic cardiology and supplies and accessories selling to hospitals, clinics and physician offices. Additionally, the company provides centralized cardiac safety and diagnostic services (QT Studies, ECG, Holter, ABP, and Event Monitoring) to biopharmaceutical companies undertaking clinical trials.

It employs approximately 1,100 personnel in its offices located in the United States, UK, Canada, France, Germany, Finland, India and Singapore.

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements include information regarding the Company's expectations, goals or intentions about the future, including, but not limited to, statements regarding the capabilities and performance of its clinical application suite. The actual results may differ materially from those described in or implied by any forward-looking statement. Other important factors are set forth in the Securities and Exchange Commission filings of OSI Systems, Inc. All forward-looking statements speak only as of the date made, and we undertake no obligation to update these forward-looking statements.

Contact Information

  • Contact Information
    Dan Prueher
    Spacelabs Healthcare
    Email Contact